Search by Keyword
Search By Theme
Search By Conditions / Disease
Ovarian Cancer Screening
IRB Number:
724-01
Trial Status:
Open for Enrollment
Why is this study being done?
This study is being done to look for molecular markers present in blood to distinguish benign (non-cancerous) ovarian tumors from ovarian cancer.
Who is Eligible to Participate in the Study?
- Age 35 and older.
- Scheduled for surgery at Mayo Clinic Rochester for removal of a pelvic mass.
- Any pelvic mass, regardless of how suspicious or benign it appears will qualify for this project.
- No previous history of ovarian or primary peritoneal cancer.
Further eligibility criteria will be discussed with you.
What will happen in the study?
- A blood sample will be taken before your planned surgery.
- We will ask you a short series of questions about medications you are taking and your medical history.
Who can I Contact for Additional Information on this Trial?
Complete Request Form for Cancer Clinical Trial Information at Mayo Clinic or
Further information can be obtained by calling Marla Kay Sommerfield, the study coordinator, at (507) 266-3053.
What is/are the Locations of this Clinical Trial?
- Rochester, MN
Last updated: 01/04/2002
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.